BioIQ

37 articles about BioIQ

• BioIQ and DermTech Enter into an Agreement to Add Non-invasive DermTech Melanoma Test to BioIQ's Health Testing Solution Lineup

  12/15/2021

  BioIQ, Inc., ("BioIQ") and DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced an agreement to bring increased patient access to precision genomics.

• BioIQ and Former TRICARE Program Director, Major General Elder Granger, M.D., Discuss How Employers Can Use Military Strategies to Innovate Health and Wellness Programs

  8/19/2021

  BioIQ announces the release of a new on-demand webinar.

• BioIQ Announces Webinar with Cambia Health Solutions Senior Vice President of Health Care Services Dr. Marion Couch on How COVID-19 Drove Innovation in Healthcare

  7/7/2021

  BioIQ  announces the availability of a new on-demand episode in the company's ongoing webinar series featuring health insights from industry leaders.

• Healthcare Access Advocates Randy Pate and Donato Tramuto Join BioIQ Webinar Series to Discuss Avenues to Overcome US Health Disparities

  5/20/2021

  The webinars highlight ways employers, payers, and government programs can improve healthcare affordability and outcomes for underserved populations.

• BioIQ and MLU Services Inc. Partner to Bring Mobile COVID-19 Vaccinations to Rural America

  4/15/2021

  The collaboration brings mobile and site-based vaccination operations and population engagement expertise together to improve vaccination distribution in underserved areas.

• BioIQ Announces Webinar with Dr. Darria Long Addressing Breaking Research on What it Will Take to Safely Resume In-Person Learning Nationally

  3/31/2021

  BioIQ's webinar series highlights critical healthcare issues facing America's education and business leaders in 2021, from national health policy to COVID-19 testing and vaccination strategy.

• BioIQ Launches New Telehealth Solution for Diagnostic Testing and Population Health

  3/3/2021

  The acquisition brings behavioral science, AI, and virtual care enhancements to the BioIQ digital health testing platform.

• BioIQ Partners with Fulgent Genetics to Bring COVID-19 Variant Detection to COVID-19 Testing Programs

  2/16/2021

  The groundbreaking viral genome sequencing and reflex testing solution identifies various COVID-19 variant strains, enabling employers, health plans, and public health agencies to optimize surveillance, treatment and vaccination protocol to mitigate spread of the virus more effectively.

• BioIQ and Biomeme Announce Partnership for COVID Testing, Bringing the RT-PCR Laboratory and Gold-Standard Testing to the Worksite for Fast and Highly Sensitive Results

  2/11/2021

  The partnership expands BioIQ’s fully integrated healthcare services to include Biomeme’s on-site testing platform to provide accurate, real-time RT-PCR COVID-19 test results with centralized access to test scheduling and digital program management for employers, health plans, and consumers.

• 7 of 10 Fully Insured Americans Represented by BioIQ in 2020

  1/27/2021

  BioIQ’s population health testing platform was a key solution in the pandemic for millions of Americans, including those with social determinants of health.

•  BioIQ Announces Partnership with Validation Institute to Validate Results of Its Healthcare Testing

  9/24/2020

  BioIQ announced today a partnership with world-renowned Validation Institute for first-of-its-kind medical testing validation. This partnership will validate the impact of screening and diagnostic testing, providing clarity in

• BioIQ is First Georgia Company Approved as Qualified Vendor for Georgia Entertainment Investment Tax Credits

  9/16/2020

  Production companies can qualify for 30 percent in tax credits using BioIQ's COVID-19 testing solution to safely bring workers back and resume filming in Georgia.   [16-September-2020]   ATLANTA , Sept. 16, 2020 /PRNewswire/ -- BioIQ , an aggregator of testing solutions and optimizer of lab capacity for leading employers and health plans, announces that it is the first

• EY Announces Justin Bellante of BioIQ as an Entrepreneur Of The Year® 2020 Southeast Award Finalist

  8/18/2020

  Ernst & Young LLP announced that Justin Bellante of BioIQ was named an Entrepreneur Of The Year® 2020 Southeast Award finalist.

• BioIQ and Phosphorus Genomics Expand COVID-19 Testing Network with At-Home Saliva Test Kit

  6/17/2020

  The self-administered COVID-19 sample collection kit offers consumers, employers, and government agencies increased capacity for home testing with the expertise of leading genomics and sequencing experts   [17-June-2020]   ATLANTA , June 17, 2020 /PRNewswire/ --  BioIQ , a healthcare engagement and clinical adherence technology platform company, and Phosphorus , a leadin

• 

  Biopharma Update on the Novel Coronavirus: June 17

  6/17/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 17, 2020.

• BioIQ Launches First Home Test Combining COVID-19, Flu A / Flu B, and 21 Test Respiratory Panel from a Single Sample with P23 Labs

  6/15/2020

  BioIQ , a healthcare engagement and clinical adherence technology platform company, announced today availability of the first home test for COVID-19 that combines COVID-19, Flu A / Flu B, and a 21 Test Respiratory Pa

• BioIQ Expands Return-to-Office Support Ecosystem to Help Employers Navigate COVID-19 Testing, Legal, and Workspace Considerations

  6/5/2020

  The screening and workforce reentry solution includes clinically overseen COVID-19 diagnostic and antibody testing; a population analytics, engagement, and monitoring technology platform; and a comprehensive return-to-work action plan.   [05-June-2020]   ATLANTA , June 5, 2020 /PRNewswire/ --  BioIQ , a healthcare engagement and clinical adherence technology platform comp

• BioIQ Launches Telehealth Enabled At-Home Saliva Test Kit for COVID-19 with P23 Labs

  6/2/2020

  The self-administered COVID-19 sample collection kit integrates comprehensive telehealth support with the ease and convenience of at-home saliva collection.

• BioIQ and Matrix Medical Network Unveil Back-to-Work COVID-19 Testing Program for US Employers

  4/29/2020

  The employee analytics, engagement, monitoring and testing solution is designed to protect workers and foster confidence as employers lay out plans for workforce re-entry.

• BioIQ Adds Antibody Testing to its COVID-19 Testing Platform

  4/15/2020

  Antibody testing is anticipated to play a critical role in getting people back to work and revitalizing the economy.